Skip to main content
Recall Canary
Divalproex Sodium Delayed-Release Tablets 500 mg
← Back to all recalls
DRUG RECALLMODERATE

Divalproex Sodium Delayed-Release Tablets 500 mg

Bionpharma recalls Divalproex Sodium 500 mg tablets due to foreign tablets/capsules.

What to do

Consumers who have the affected product should stop using it and contact Bionpharma Inc. for instructions on return or disposal.

Recalled
Listed
Updated
Recall No.
D-0742-2026
Agency
FDA
Firm
Bionpharma Inc.
Recall ID
99316
Status
ONGOING

Why it was recalled

Bionpharma Inc. is recalling Divalproex Sodium Delayed-Release Tablets, USP, 500 mg, 500-count bottles, due to the presence of foreign tablets or capsules in the product.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Divalproex Sodium Delayed-Release Tablets, USP

Lot code
704C003, 2028
Strength
500 mg
NDC / UPC
NDC 69452-435-30

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Foreign Material recalls

Other recent recalls from Bionpharma Inc.

All recalls from Bionpharma Inc.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-07 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification